Navigation Links
Actelion Launches Increased Strength Formulation of Ventavis (Iloprost) for Pulmonary Arterial Hypertension in the United States
Date:9/1/2009

The available therapies have positive effects in PAH, but they do not provide a cure, and in many patients the disease will progress. PAH remains a serious life-threatening condition (2,3). Early recognition and an understanding of the selection and timing of therapeutic options remain critical elements in the optimal management of patients with this disorder.

References

  1. Farber HW; Loscalzo J. Mechanisms of disease: pulmonary arterial hypertension. N. Eng. J. Med. 2004; 351:1655-65.
  2. Humbert M; Sitbon O; Simonneau G. Treatment of pulmonary arterial hypertension. N. Eng. J. Med. 2004;351:1425-36.
  3. Humbert M; Morrell NW; Archer SL; et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 2004; 43: Suppl. 12: 13S-24S.

Actelion Ltd

Actelion Ltd is a biopharmaceutical company with its corporate headquarters in Allschwil/Basel, Switzerland. Actelion's first drug Tracleer(R), an orally available dual endothelin receptor antagonist, has been approved as a therapy for pulmonary arterial hypertension. Actelion markets Tracleer(R) through its own subsidiaries in key markets worldwide, including the United States (based in South San Francisco), the European Union, Japan, Canada, Australia and Switzerland. Actelion, founded in late 1997, is a leading player in innovative science related to the endothelium - the single layer of cells separating every blood vessel from the blood stream. Actelion's over 2000 employees focus on the discovery, development and marketing of innovative drugs for significant unmet medical needs. Actelion shares are traded on the SIX Swiss Exchange (ticker symbol: ATLN) as part of the Swiss blue-chip index SMI (Swiss Market Index SMI(R)).


'/>"/>
SOURCE Actelion Pharmaceuticals US, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Actelion Announces Multiple Presentations on Tracleer(R) and the REVEAL Registry at CHEST 2007
2. Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information
3. GeneraMedix, Inc. Announces Sale of Innovative Epoprostenol Formulation to Actelion Ltd.
4. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
5. Novozymes Launches Enzyme to Reduce Acrylamide in Food
6. Enova Medical Launches Exos Corporation
7. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
8. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
9. ThirdBiotech Networking Group Launches
10. BioReliance Launches Next-Generation Genotoxicity Screening Service
11. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... the National Institutes of Health (NIH), awarded a $2.18 million ... a non-invasive, passive diffusion-based treatment for severe, non-infectious uveitis. ... ... UT (PRWEB) December 10, 2009 -- The National Eye Institute ... awarded a $2.18 million grant to Aciont Inc. to help ...
(Date:12/10/2009)... - YM BioSciences Inc. (NYSE Amex: YMI ... company that identifies and advances a diverse portfolio ... development, today provided an update on the proposed ... Cytopia Ltd. into YM, details of which were ... directors of Cytopia has unanimously recommended that its ...
(Date:12/10/2009)... Vivakor, Inc. (OTC Bulletin Board: VIVK) today ... exclusive, $5 million license agreement with consumer ... ). The agreement exclusively licenses to ... nutraceutical formulation developed by Vivakor and provides ... Vivakor for Regeneca. Under the terms of ...
(Date:12/10/2009)... Martek Biosciences Corporation (NASDAQ: MATK) announced today that it ... global dairy company Fonterra Co-operative Group Limited for the use ... Materna products for pregnant and nursing mothers. , ... ... Martek Biosciences Corporation (NASDAQ: MATK) announced today that ...
Breaking Biology Technology:NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3
... of us, gold is only valuable if we possess ... rule isn,t the case for those interested in exploiting ... chemical reactions, including the oxidation of poisonous carbon monoxide ... process, if industrialized, could potentially improve the effectiveness of ...
... Men in the Los,Angeles area who suffer from ... the option of out-patient, in-office treatment to cure,the ... now offering the,LIFE(TM) (Laser Induced Flow Enhancement) procedure ... LIFE(TM) procedure is a breakthrough,laser treatment for benign ...
... 10 - 11, ... 2008 San Jose, California, ... Plexus Online on-demand software for the medical manufacturing,enterprise, is exhibiting ... San Jose McEnery Conference Center, San Jose,California., (Logo: ...
Other Biology Technology:NIST and partners identify tiny gold clusters as top-notch catalysts 2Orange Coast Urology Offers Advanced In-Office Patient EVOLVE(R) Laser Prostate Treatment 2Plexus Systems, Inc. to Exhibit at BIOMEDevice Medical Technology Conference 2
(Date:12/14/2009)... December 10, 2009If you are spending the holidays with ... whether you would be better off with another family, ... , A research team from McMaster University and the ... cichlids, a species that lives in groups, members make ... results appear in the current issue of Biology ...
(Date:12/14/2009)... good as laparoscopy is in preventing some of the stresses ... including reduced blood flow and organ dysfunction. Laparoscopy is a ... , By adding another gas to ... laparoscopy, researchers at Duke University Medical Center have found they ... , The gas ethyl nitrite (ENO) helped to open blood ...
(Date:12/13/2009)... Scripps Research Institute have solved a 10-year-old mystery ... family of enzymes can have two completely distinct ... guidance for understanding other molecules in the family, ... protein,s possible use for combating diseases including cancer ... in the December 13, 2009 advance, online issue ...
Breaking Biology News(10 mins):Gas improves blood flow and organ status during minimally invasive surgery 2Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3The Michael J Fox Foundation Announces 241 5 Million in Funding to Advance Development of Drug Targets for Disease Modifying Parkinsons Disease Trea 15002 1The Michael J Fox Foundation Announces 241 5 Million in Funding to Advance Development of Drug Targets for Disease Modifying Parkinsons Disease Trea 15002 2The Michael J Fox Foundation Announces 241 5 Million in Funding to Advance Development of Drug Targets for Disease Modifying Parkinsons Disease Trea 15002 3Breast Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 6610 1Breast Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 6610 2Covance to Present at Piper Jaffray 21st Annual Health Care Conference 6608 1
... issue of Molecular Cell, Case Western Reserve University School ... biologys established body of evidence and widely-accepted model for ... Ambro van Hoof, Ph.D. of The University of Texas ... UTR model and proved it could not explain how ...
... elixir of all life, water is a very unusual substance: ... apart from other solids and liquids commonly found in nature. ... -- an effect known to anyone whose plumbing has burst ... list of special characteristics. (Most liquids contract when they freeze.) ...
... in French . Rio Tinto ... a $1-million donation to the Thinking Ahead Campaign at ... McGill University and the McGill University Health Centre. The ... people and expand facilities and services. , The ...
Other Biology News:Case researcher in RNA biology makes waves by challenging current thinking 2Weird water: Discovery challenges long-held beliefs about water's special properties 2Weird water: Discovery challenges long-held beliefs about water's special properties 3Building the future -- 21st century nano tools to repair the nervous system 2
... This CLS number is a new product ... number. If showing no availability yet, please ... or contact customer service for assistance. ... Comp Dim: D H 100 ...
BD BioCoat BD MatrigelTM Matrix 100 mm Culture Dishes for hepatocytes, tissue-culture treated polystyrene with a uniform application of MATRIGEL Matrix....
...
... 5-OxoETE-d7 is used as an internal standard ... isotope dilution mass spectrometry. 5-OxoETE is a ... of 5-HETE in human neutrophils. It stimulates ... EC50 of 2 nM. 5-OxoETE selectively stimulates ...
Biology Products: